You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / INDSWIFT

INDSWIFT
Intrinsic Value | Fundamental Analysis

Returns | 1W : 20.7% , 1M : 59.1%,1Y : 340.9%
www.indswift.com
BOM : 524652     NSE : INDSWFTLTD    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : NA
Oct 14,2021
Price(EOD): Rs. 15.27
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Affiliate Link.
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
INDSWIFT 20.7% 59.1% 340.9%
SUN PHARMACEUTICAL INDUSTRIES 2.4% 7.8% 64%
DIVIS LABORATORIES 6% 4.2% 64.4%
DR REDDYS LABORATORIES 2.3% -0.1% -5.5%
CIPLA -0.6% -4.4% 12.2%
GLAND PHARMA -1.9% -5.9% NA
PIRAMAL ENTERPRISES 3.7% 7.1% 112.8%
CADILA HEALTHCARE -1.1% -3.8% 23.7%
TORRENT PHARMACEUTICALS 1.9% 0.2% 10.2%


FUNDAMENTAL ANALYSIS OF INDSWIFT

 
Fundamentals Score
[ Q(TTM): Jun2021, Y: Mar2020
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]
Show Me the Stocks with Fundamentals better than INDSWIFT Plus/Pro


VALUATION OF INDSWIFT

 
Valuation Score
[As on : Oct 14,2021 ]

Ratio Standalone
P/E
P/B
P/S
-
P/E Calculated based on EPS of -3.53
[ Mar2020 - Standalone Results ]

-
P/B Calculated based on Book Value of -131.66
[ Mar2020 - Standalone Results ]

0.21
P/S Calculated based on Revenues of 385.169 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than INDSWIFT Plus/Pro


FAIR VALUE OF INDSWIFT

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
-78%
105%

SHARE PRICE MOMENTUM OF INDSWIFT

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
-1.43
-1.49
-1.55
-1.49
-
-
-1.57
-0.52
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-3.82%
2260.04%
81.63%
79.58%
47.48%
9.66%
64.46%
59.74%
QtrlyTrend
6
Latest Qtr: Jun2021

INDSWIFT related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ [Frequently Asked Questions]


Is INDSWIFT good for long term investment?

As on 14-Oct-2021, the Fundamentals of INDSWIFT look Poor and hence it may not be good for long term investment ! See Financial Performance of INDSWIFT . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is INDSWIFT UnderValued or OverValued?

As on 14-Oct-2021, INDSWIFT is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of INDSWIFT ?

As on 14-Oct-2021, the Intrinsic Value of INDSWIFT is Rs. 38.97 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -20.18
Fair Value [Median EV / Sales Model] : Rs. 70.48
Fair Value [Median Price / Sales Model] : Rs. 7.45
Median Fair Value of INDSWIFT : Rs. 38.97

Is INDSWIFT trading at a Premium or Discount?

As on 14-Oct-2021, INDSWIFT is trading at a Discount of -61% based on the estimates of Median Intrinsic Value!

What is the Financial Performance of Industry Peers of INDSWIFT ?

Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of GLAND PHARMA LTD | BOM: 543245 | NSE: GLAND
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of GLAND PHARMA LTD

What are the Frequent Comparisons in this Industry?

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z